Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy

L. Segat, M. Morgutti, E. Athanasakis, C. Trevisiol, A. Amaddeo, F. Poli, S. Crovella

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Cystic fibrosis (CF) transmembrane regulator protein (CFTR) gene is undoubtedly the main genetic factor involved in the modulation of CF phenotype. However, other factors such as human defensins and the genes encoding for these antimicrobial peptides have been hypothesized as possible modifiers influencing airways infection in CF patients, but their role in the pathogenesis of lung disease is still debated. Since DEFB1 gene encoding for human beta-defensin 1 displays features such as antimicrobial or chemotactic activity playing a role in inflammation, it has been considered as a possible candidate CF modifier gene. We analysed three single nucleotide polymorphisms (SNPs) in the 5'- untranslated region of the DEFB1 gene (namely g- 52G>A, g-44C>G and g-20G>A) in a group of 62 CF patients from North Eastern Italy, and in 130 healthy controls, with the aim of verifying the possible association of these functional SNPs with the pulmonary phenotype of CF patients. DEFB1 SNPs have been genotyped by using Taqman allele-specific fluorescent probes and a real-time PCR platform. No significant differences were found for allele, genotype and haplotype frequencies of DEFB1 g-52G>A, g-44C>G and g- 20G>A SNPs in CF patients stratified for Pseudomonas aeruginosa infection, as well as in patients with a severe and mild clinical phenotype or in patients stratified for CFTR genotypes. DEFB1 allele, genotype and haplotype frequencies of CF patients globally considered were similar to those of healthy controls. Our findings are discordant with respect to another recent study performed on CF patients coming from Southern Italy, probably due to different ethnicity of the patients.

Original languageEnglish
Pages (from-to)169-175
Number of pages7
JournalInternational Journal of Immunogenetics
Volume37
Issue number3
DOIs
Publication statusPublished - 2010

Fingerprint

Cystic Fibrosis
Italy
Single Nucleotide Polymorphism
Alleles
Genotype
Phenotype
Haplotypes
Modifier Genes
Genes
Defensins
Pseudomonas Infections
5' Untranslated Regions
Regulator Genes
Fluorescent Dyes
Pseudomonas aeruginosa
Lung Diseases
Real-Time Polymerase Chain Reaction
Proteins
Inflammation
Peptides

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Immunology
  • Genetics(clinical)
  • Medicine(all)

Cite this

Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy. / Segat, L.; Morgutti, M.; Athanasakis, E.; Trevisiol, C.; Amaddeo, A.; Poli, F.; Crovella, S.

In: International Journal of Immunogenetics, Vol. 37, No. 3, 2010, p. 169-175.

Research output: Contribution to journalArticle

Segat, L. ; Morgutti, M. ; Athanasakis, E. ; Trevisiol, C. ; Amaddeo, A. ; Poli, F. ; Crovella, S. / Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy. In: International Journal of Immunogenetics. 2010 ; Vol. 37, No. 3. pp. 169-175.
@article{911a9aff37b14509b7275d3274990a38,
title = "Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy",
abstract = "Cystic fibrosis (CF) transmembrane regulator protein (CFTR) gene is undoubtedly the main genetic factor involved in the modulation of CF phenotype. However, other factors such as human defensins and the genes encoding for these antimicrobial peptides have been hypothesized as possible modifiers influencing airways infection in CF patients, but their role in the pathogenesis of lung disease is still debated. Since DEFB1 gene encoding for human beta-defensin 1 displays features such as antimicrobial or chemotactic activity playing a role in inflammation, it has been considered as a possible candidate CF modifier gene. We analysed three single nucleotide polymorphisms (SNPs) in the 5'- untranslated region of the DEFB1 gene (namely g- 52G>A, g-44C>G and g-20G>A) in a group of 62 CF patients from North Eastern Italy, and in 130 healthy controls, with the aim of verifying the possible association of these functional SNPs with the pulmonary phenotype of CF patients. DEFB1 SNPs have been genotyped by using Taqman allele-specific fluorescent probes and a real-time PCR platform. No significant differences were found for allele, genotype and haplotype frequencies of DEFB1 g-52G>A, g-44C>G and g- 20G>A SNPs in CF patients stratified for Pseudomonas aeruginosa infection, as well as in patients with a severe and mild clinical phenotype or in patients stratified for CFTR genotypes. DEFB1 allele, genotype and haplotype frequencies of CF patients globally considered were similar to those of healthy controls. Our findings are discordant with respect to another recent study performed on CF patients coming from Southern Italy, probably due to different ethnicity of the patients.",
author = "L. Segat and M. Morgutti and E. Athanasakis and C. Trevisiol and A. Amaddeo and F. Poli and S. Crovella",
year = "2010",
doi = "10.1111/j.1744-313X.2010.00907.x",
language = "English",
volume = "37",
pages = "169--175",
journal = "International Journal of Immunogenetics",
issn = "1744-3121",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy

AU - Segat, L.

AU - Morgutti, M.

AU - Athanasakis, E.

AU - Trevisiol, C.

AU - Amaddeo, A.

AU - Poli, F.

AU - Crovella, S.

PY - 2010

Y1 - 2010

N2 - Cystic fibrosis (CF) transmembrane regulator protein (CFTR) gene is undoubtedly the main genetic factor involved in the modulation of CF phenotype. However, other factors such as human defensins and the genes encoding for these antimicrobial peptides have been hypothesized as possible modifiers influencing airways infection in CF patients, but their role in the pathogenesis of lung disease is still debated. Since DEFB1 gene encoding for human beta-defensin 1 displays features such as antimicrobial or chemotactic activity playing a role in inflammation, it has been considered as a possible candidate CF modifier gene. We analysed three single nucleotide polymorphisms (SNPs) in the 5'- untranslated region of the DEFB1 gene (namely g- 52G>A, g-44C>G and g-20G>A) in a group of 62 CF patients from North Eastern Italy, and in 130 healthy controls, with the aim of verifying the possible association of these functional SNPs with the pulmonary phenotype of CF patients. DEFB1 SNPs have been genotyped by using Taqman allele-specific fluorescent probes and a real-time PCR platform. No significant differences were found for allele, genotype and haplotype frequencies of DEFB1 g-52G>A, g-44C>G and g- 20G>A SNPs in CF patients stratified for Pseudomonas aeruginosa infection, as well as in patients with a severe and mild clinical phenotype or in patients stratified for CFTR genotypes. DEFB1 allele, genotype and haplotype frequencies of CF patients globally considered were similar to those of healthy controls. Our findings are discordant with respect to another recent study performed on CF patients coming from Southern Italy, probably due to different ethnicity of the patients.

AB - Cystic fibrosis (CF) transmembrane regulator protein (CFTR) gene is undoubtedly the main genetic factor involved in the modulation of CF phenotype. However, other factors such as human defensins and the genes encoding for these antimicrobial peptides have been hypothesized as possible modifiers influencing airways infection in CF patients, but their role in the pathogenesis of lung disease is still debated. Since DEFB1 gene encoding for human beta-defensin 1 displays features such as antimicrobial or chemotactic activity playing a role in inflammation, it has been considered as a possible candidate CF modifier gene. We analysed three single nucleotide polymorphisms (SNPs) in the 5'- untranslated region of the DEFB1 gene (namely g- 52G>A, g-44C>G and g-20G>A) in a group of 62 CF patients from North Eastern Italy, and in 130 healthy controls, with the aim of verifying the possible association of these functional SNPs with the pulmonary phenotype of CF patients. DEFB1 SNPs have been genotyped by using Taqman allele-specific fluorescent probes and a real-time PCR platform. No significant differences were found for allele, genotype and haplotype frequencies of DEFB1 g-52G>A, g-44C>G and g- 20G>A SNPs in CF patients stratified for Pseudomonas aeruginosa infection, as well as in patients with a severe and mild clinical phenotype or in patients stratified for CFTR genotypes. DEFB1 allele, genotype and haplotype frequencies of CF patients globally considered were similar to those of healthy controls. Our findings are discordant with respect to another recent study performed on CF patients coming from Southern Italy, probably due to different ethnicity of the patients.

UR - http://www.scopus.com/inward/record.url?scp=77953566873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953566873&partnerID=8YFLogxK

U2 - 10.1111/j.1744-313X.2010.00907.x

DO - 10.1111/j.1744-313X.2010.00907.x

M3 - Article

C2 - 20193032

AN - SCOPUS:77953566873

VL - 37

SP - 169

EP - 175

JO - International Journal of Immunogenetics

JF - International Journal of Immunogenetics

SN - 1744-3121

IS - 3

ER -